rofecoxib market

Global Rofecoxib Market Research Report 2023(Status and Outlook)

  • Published Date: 2023-08-20
  • Report ID: 146281
  • Pages: 250
  • Format: prudent report format


Report Overview
Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.Rofecoxib was available by prescription in both tablet-form and as an oral suspension.
Prudent Markets latest report provides a deep insight into the global Rofecoxib market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Rofecoxib Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Rofecoxib market in any manner.
Global Rofecoxib Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau

Market Segmentation (by Type)
Oral Suspension.
Tablet-Form

Market Segmentation (by Application)
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Rofecoxib Market
Overview of the regional outlook of the Rofecoxib Market:

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Rofecoxib Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Rofecoxib
1.2 Key Market Segments
1.2.1 Rofecoxib Segment by Type
1.2.2 Rofecoxib Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Rofecoxib Market Overview
2.1 Global Market Overview
2.1.1 Global Rofecoxib Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Rofecoxib Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Rofecoxib Market Competitive Landscape
3.1 Global Rofecoxib Sales by Manufacturers (2018-2023)
3.2 Global Rofecoxib Revenue Market Share by Manufacturers (2018-2023)
3.3 Rofecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Rofecoxib Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Rofecoxib Sales Sites, Area Served, Product Type
3.6 Rofecoxib Market Competitive Situation and Trends
3.6.1 Rofecoxib Market Concentration Rate
3.6.2 Global 5 and 10 Largest Rofecoxib Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Rofecoxib Industry Chain Analysis
4.1 Rofecoxib Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Rofecoxib Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Rofecoxib Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Rofecoxib Sales Market Share by Type (2018-2023)
6.3 Global Rofecoxib Market Size Market Share by Type (2018-2023)
6.4 Global Rofecoxib Price by Type (2018-2023)
7 Rofecoxib Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Rofecoxib Market Sales by Application (2018-2023)
7.3 Global Rofecoxib Market Size (M USD) by Application (2018-2023)
7.4 Global Rofecoxib Sales Growth Rate by Application (2018-2023)
8 Rofecoxib Market Segmentation by Region
8.1 Global Rofecoxib Sales by Region
8.1.1 Global Rofecoxib Sales by Region
8.1.2 Global Rofecoxib Sales Market Share by Region
8.2 North America
8.2.1 North America Rofecoxib Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Rofecoxib Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Rofecoxib Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Rofecoxib Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Rofecoxib Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Rofecoxib Basic Information
9.1.2 Merck Rofecoxib Product Overview
9.1.3 Merck Rofecoxib Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Rofecoxib SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Chengdu Meinkai Chemical Co. LTD
9.2.1 Chengdu Meinkai Chemical Co. LTD Rofecoxib Basic Information
9.2.2 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Overview
9.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Market Performance
9.2.4 Chengdu Meinkai Chemical Co. LTD Business Overview
9.2.5 Chengdu Meinkai Chemical Co. LTD Rofecoxib SWOT Analysis
9.2.6 Chengdu Meinkai Chemical Co. LTD Recent Developments
9.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
9.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Basic Information
9.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Overview
9.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Market Performance
9.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Business Overview
9.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib SWOT Analysis
9.3.6 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments
9.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
9.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Basic Information
9.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Overview
9.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Market Performance
9.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Business Overview
9.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib SWOT Analysis
9.4.6 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments
9.5 Pfizer
9.5.1 Pfizer Rofecoxib Basic Information
9.5.2 Pfizer Rofecoxib Product Overview
9.5.3 Pfizer Rofecoxib Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Rofecoxib SWOT Analysis
9.5.6 Pfizer Recent Developments
9.6 Tremeau
9.6.1 Tremeau Rofecoxib Basic Information
9.6.2 Tremeau Rofecoxib Product Overview
9.6.3 Tremeau Rofecoxib Product Market Performance
9.6.4 Tremeau Business Overview
9.6.5 Tremeau Recent Developments
10 Rofecoxib Market Forecast by Region
10.1 Global Rofecoxib Market Size Forecast
10.2 Global Rofecoxib Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Rofecoxib Market Size Forecast by Country
10.2.3 Asia Pacific Rofecoxib Market Size Forecast by Region
10.2.4 South America Rofecoxib Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Rofecoxib by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Rofecoxib Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Rofecoxib by Type (2024-2029)
11.1.2 Global Rofecoxib Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Rofecoxib by Type (2024-2029)
11.2 Global Rofecoxib Market Forecast by Application (2024-2029)
11.2.1 Global Rofecoxib Sales (K MT) Forecast by Application
11.2.2 Global Rofecoxib Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.